Complete atrioventricular block associated with dapsone therapy: A rare complication of dapsone-induced hypersensitivity syndrome

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 4, 2009, Pages 489-492

  Zhu, K J ^a   He, F T ^a   Jin, N ^a   Lou, J X ^a   Cheng, H ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Complete atrioventricular block; Dapsone hypersensitivity syndrome; Syncope

Indexed keywords

DAPSONE; IMMUNOGLOBULIN; LORATADINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CLINICAL FEATURE; COMPLETE HEART BLOCK; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; LABORATORY TEST; PHYSICAL EXAMINATION; PUSTULOSIS PALMOPLANTARIS; SYNCOPE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANTI-INFECTIVE AGENTS; ATRIOVENTRICULAR BLOCK; DAPSONE; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PSORIASIS; SYNCOPE;

EID: 67651247246     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00991.x     Document Type: Article

References (12)

1. Zhu YI, Stiller MJ (2001) Dapsone and sulfones in dermatology: overview and update. Journal of the American Academic Dermatology, 45, 420 434.
2. Kosseifi SG, Guha B, Nassour DN, Chi DS, Krishnaswamy G (2006) The dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations. Journal of Occupational Medicine and Toxicology, 1, 9.
3. Farber EM, Nall L (1993) Pustular psoriasis. Cutis, 51, 29 32.
4. Sener O, Doganci L, Safali M, Besirbellioglu B, Bulucu F, Pahsa A (2006) Severe dapsone hypersensitivity syndrome. Journal of Investigational Allergology & Clinical Immunology, 16, 268 270.
5. Aldday EJ, Barnes J (1951) Toxic effects of diaminodiphenylsulphone in leprosy. Lancet, 2, 205 206.
6. Thong BY, Leong KP, Chng HH (2002) Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalarial prophylaxis. Annals of Allergy, Asthma and Immunology, 88, 527 529.
7. Teo RY, Tay YK, Tan CH, Ng V, Oh DC (2006) Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis. Annals of Academy of Medicine Singapore, 35, 833 836.
8. Agrawal S, Agarwalla A (2005) Dapsone hypersensitivity syndrome: a clinico-epidemiological review. Journal of Dermatology, 32, 883 889.
9. Coleman MD, Coleman NA (1996) Drug-induced methaemoglobinaemia. Treatment issues. Drug Safety, 14, 394 405.
10. Kumari R, Uppal SS (2005) First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature. Rheumatology International, 26, 70 73.
11. Sekine N, Motokura T, Oki T et al. (2001) Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA, 285, 1153 1154.
12. Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS (2006) Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. Journal of the American Academic Dermatologly, 54, s14 s17.